12-8847640-G-T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2

The NM_144670.6(A2ML1):​c.1775G>T​(p.Arg592Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000644 in 1,613,426 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R592W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00067 ( 0 hom. )

Consequence

A2ML1
NM_144670.6 missense

Scores

3
9
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 2.07

Publications

13 publications found
Variant links:
Genes affected
A2ML1 (HGNC:23336): (alpha-2-macroglobulin like 1) This gene encodes a member of the alpha-macroglobulin superfamily. The encoded protein is thought to be an N-glycosylated monomeric protein that acts as an inhibitor of several proteases. It has been shown to form covalent interactions with proteases, and has been reported as the p170 antigen recognized by autoantibodies in the autoimmune disease paraneoplastic pemphigus (PNP; PMID:20805888). Mutations in these gene have also been associated with some cases of Noonan syndrome (NS; PMID:24939586) as well as some cases of otitis media (PMID:26121085). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
A2ML1 Gene-Disease associations (from GenCC):
  • Noonan syndrome
    Inheritance: AD Classification: SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP6
Variant 12-8847640-G-T is Benign according to our data. Variant chr12-8847640-G-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 203521.
BS2
High AC in GnomAd4 at 60 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
A2ML1NM_144670.6 linkc.1775G>T p.Arg592Leu missense_variant Exon 15 of 36 ENST00000299698.12 NP_653271.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
A2ML1ENST00000299698.12 linkc.1775G>T p.Arg592Leu missense_variant Exon 15 of 36 1 NM_144670.6 ENSP00000299698.7

Frequencies

GnomAD3 genomes
AF:
0.000394
AC:
60
AN:
152144
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000588
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000382
AC:
95
AN:
248816
AF XY:
0.000341
show subpopulations
Gnomad AFR exome
AF:
0.000259
Gnomad AMR exome
AF:
0.000291
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000186
Gnomad NFE exome
AF:
0.000655
Gnomad OTH exome
AF:
0.000497
GnomAD4 exome
AF:
0.000670
AC:
979
AN:
1461282
Hom.:
0
Cov.:
30
AF XY:
0.000623
AC XY:
453
AN XY:
726942
show subpopulations
African (AFR)
AF:
0.0000897
AC:
3
AN:
33454
American (AMR)
AF:
0.000224
AC:
10
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39648
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86178
European-Finnish (FIN)
AF:
0.000131
AC:
7
AN:
53340
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000822
AC:
914
AN:
1111710
Other (OTH)
AF:
0.000729
AC:
44
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
55
109
164
218
273
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000394
AC:
60
AN:
152144
Hom.:
0
Cov.:
32
AF XY:
0.000256
AC XY:
19
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.000338
AC:
14
AN:
41438
American (AMR)
AF:
0.000131
AC:
2
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000588
AC:
40
AN:
68020
Other (OTH)
AF:
0.00144
AC:
3
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00000945
Hom.:
2
Bravo
AF:
0.000419
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000257
AC:
1
ESP6500EA
AF:
0.000604
AC:
5
ExAC
AF:
0.000430
AC:
52
EpiCase
AF:
0.000709
EpiControl
AF:
0.000950

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Apr 03, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Expression in a zebrafish model led to developmental defects including broad forehead, blunted face, and cardiac malformations (Vissers et al., 2015); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 24939586, 27942422)

Mar 01, 2015
OMIM
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

Dec 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 592 of the A2ML1 protein (p.Arg592Leu). This variant is present in population databases (rs200673370, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with clinical features of Noonan syndrome (PMID: 24939586, 33082526). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 203521). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects A2ML1 function (PMID: 24939586). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

not specified Uncertain:1
Jun 01, 2020
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: A2ML1 c.1775G>T (p.Arg592Leu) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00038 in 248816 control chromosomes. The observed variant frequency is approximately 95 fold of the estimated maximal expected allele frequency for a pathogenic variant in A2ML1 causing Noonan Syndrome And Related Conditions phenotype (4e-06), strongly suggesting that the variant is benign. However, c.1775G>T has been reported in the literature in one multi-generation family affected with Noonan Syndrome (Vissers_2015). Co-segregation was seen in all affected family members. This variant has also been reported in one patient with Kabuki syndrome who also carries a de novo pathogenic variant (KMT2D c.4148G>A/p.C1383Y, Long_2016). One functional study in Zebrafish showed that p.S600L (mimicing human p.R592L) caused developmental defects (Vissers_2015). Since the wild-type amino acid in Zebrafish is different to human A2ML1, this result does not allow convincing conclusions about the variant effect. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.026
T;T;.;T
Eigen
Uncertain
0.33
Eigen_PC
Uncertain
0.24
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.82
T;T;D;D
M_CAP
Pathogenic
0.35
D
MetaRNN
Uncertain
0.52
D;D;D;D
MetaSVM
Benign
-0.64
T
MutationAssessor
Uncertain
2.7
M;.;.;.
PhyloP100
2.1
PrimateAI
Uncertain
0.69
T
PROVEAN
Pathogenic
-5.6
D;D;D;D
REVEL
Pathogenic
0.75
Sift
Uncertain
0.0090
D;D;D;D
Sift4G
Uncertain
0.015
D;D;D;D
Vest4
0.82
ClinPred
0.24
T
GERP RS
2.7
Varity_R
0.38
gMVP
0.62
Mutation Taster
=12/88
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200673370; hg19: chr12-9000236; COSMIC: COSV106094181; COSMIC: COSV106094181; API